Corentec, a company specializing in the production of artificial joints, announced on Tuesday that the inaugural surgery involving its patient-specific implant (PSI) designed for artificial shoulder joints was effectively carried out at Kyungpook National University Hospital in Korea.

The PSI serves as a specialized tool for customized patient surgeries, utilizing data from a computed tomography (CT) scan to generate a three-dimensional model of the patient's bones. This enables surgeons to virtually and accurately implant the artificial joint according to the unique requirements of each individual during the surgical procedure.

PSIs for artificial shoulder joints are categorized as glenoid or humeral, and both serve as guides to ensure that the joint implant is placed exactly where it is intended.

Corentec developed products for both sites and completed Class 2 medical device certification in September last year.

Since the launch of Coralis, a shoulder artificial joint product in 2019, Corentec has been gaining momentum, currently occupying the top spot in the domestic shoulder artificial joint market. Domestically, it is also ranked first in the artificial hip joint market and third in the artificial knee joint market.

"With the success of the first shoulder artificial joint surgery PSI, Coretec has started a full-fledged entry into the digital orthopedic market," said an official from Corentec. "Starting with PSI, we will strive to develop other technologies that will stand out in the digital orthopedic market such as surgical robots and navigation guides in the future."